Biomerica (BMRA) Receivables - Net (2011 - 2026)

Biomerica has disclosed Receivables - Net across 16 years of filings, most recently posting $941000.0 for Q1 2026.

• Receivables - Net for Q1 2026 came in at $941000.0, down 25.79% year-over-year; the trailing twelve-month figure through Feb 2026 was $941000.0 (down 25.79% YoY), and the FY2025 annual result was $731000.0, down 22.81% from the prior year.
• Receivables - Net came in at $941000.0 for Q1 2026 at Biomerica, down from $947000.0 in the prior quarter.
• In the past five years, Receivables - Net ranged from a high of $1.6 million in Q3 2024 to a low of $722000.0 in Q2 2023.
• The 5-year median for Receivables - Net is $1.1 million (2023), against an average of $1.1 million.
• Across the five-year window, Receivables - Net slumped 46.81% in 2022 and soared 53.39% in 2023, its largest moves.
• Biomerica's Receivables - Net stood at $1.4 million in 2022, then slipped by 22.23% to $1.1 million in 2023, then advanced by 24.27% to $1.3 million in 2024, then fell by 28.58% to $947000.0 in 2025, then decreased by 0.63% to $941000.0 in 2026.
• The last three Receivables - Net figures came in at $941000.0 (Q1 2026), $947000.0 (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.